1. Home
  2. NARI vs JPC Comparison

NARI vs JPC Comparison

Compare NARI & JPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NARI
  • JPC
  • Stock Information
  • Founded
  • NARI 2011
  • JPC 2003
  • Country
  • NARI United States
  • JPC United States
  • Employees
  • NARI N/A
  • JPC N/A
  • Industry
  • NARI Medical/Dental Instruments
  • JPC Investment Managers
  • Sector
  • NARI Health Care
  • JPC Finance
  • Exchange
  • NARI Nasdaq
  • JPC Nasdaq
  • Market Cap
  • NARI 3.0B
  • JPC 2.6B
  • IPO Year
  • NARI 2020
  • JPC N/A
  • Fundamental
  • Price
  • NARI $49.66
  • JPC $8.05
  • Analyst Decision
  • NARI Buy
  • JPC
  • Analyst Count
  • NARI 10
  • JPC 0
  • Target Price
  • NARI $59.13
  • JPC N/A
  • AVG Volume (30 Days)
  • NARI 918.3K
  • JPC 998.5K
  • Earning Date
  • NARI 10-28-2024
  • JPC 01-01-0001
  • Dividend Yield
  • NARI N/A
  • JPC 7.57%
  • EPS Growth
  • NARI N/A
  • JPC N/A
  • EPS
  • NARI N/A
  • JPC N/A
  • Revenue
  • NARI $574,498,000.00
  • JPC N/A
  • Revenue This Year
  • NARI $24.59
  • JPC N/A
  • Revenue Next Year
  • NARI $18.28
  • JPC N/A
  • P/E Ratio
  • NARI N/A
  • JPC N/A
  • Revenue Growth
  • NARI 22.41
  • JPC N/A
  • 52 Week Low
  • NARI $36.73
  • JPC $5.94
  • 52 Week High
  • NARI $67.13
  • JPC $7.36
  • Technical
  • Relative Strength Index (RSI)
  • NARI 53.46
  • JPC 49.32
  • Support Level
  • NARI $47.96
  • JPC $7.99
  • Resistance Level
  • NARI $52.59
  • JPC $8.11
  • Average True Range (ATR)
  • NARI 2.13
  • JPC 0.06
  • MACD
  • NARI -0.36
  • JPC -0.00
  • Stochastic Oscillator
  • NARI 29.77
  • JPC 47.37

About NARI Inari Medical Inc.

Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.

About JPC Nuveen Preferred & Income Opportunities Fund

Nuveen Preferred & Income Opportunities Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. It invests its managed assets in preferred securities, and in other types of securities, primarily income-oriented securities such as corporate and taxable municipal debt and common equity.

Share on Social Networks: